R3

Alzheimer’s Diagnosis Gets Another Gate

The first oral PCSK9 inhibitor is approved. A pill will not fix cholesterol access by itself

Oral GLP-1 drugs could widen access, but high prices may do the opposite

The Most Powerful Oncology Tool This Week Was a Check-In

Myeloma Patients May Not Need Treatment Forever

Britain Has A £1 Billion Pandemic Plan.

Alzheimer’s Treatment Moves Home. Risk Does Not.

El Salvador Eliminated Trachoma. The Certificate Is Not The Finish Line.

Duchenne Evidence Moves Into the Muscle
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
